Monitor the next 10-Q or 10-K for any restatements, material weaknesses, or further deterioration in financial condition. The going-concern qualification already present suggests the company may face liquidity or operational challenges.
Price Chart
Executive Summary
Goldenwell Biotech dismissed its auditor, Michael Gillespie & Associates, and hired Privatco CPA Limited. The former auditor's reports had included a going-concern qualification, but no disagreements or reportable events were cited. Auditor switches, especially to a smaller firm, are a red flag for financial reporting quality and often precede adverse developments.
Key Facts
- Dismissed auditor Michael Gillespie & Associates on September 27, 2026.
- New auditor is Privatco CPA Limited, engaged September 22, 2026.
- Former auditor's reports contained a going-concern qualification for years ended December 31, 2025 and 2024.
- No disagreements or reportable events were reported between the company and former auditor.
- The company is an emerging growth company.
Financial Impact
Auditor switch to a smaller firm increases risk of financial reporting issues; going-concern qualification already signals distress.
Risk Factors
- Potential for undisclosed accounting issues or disagreements that led to the auditor change.
- Increased likelihood of future restatements or delayed filings.
- Going-concern risk already flagged by former auditor.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-005892 |
| Document: gdwl_ex161.htm | 0001477932-26-005892 |
| Document: 0001477932-26-005892-index-headers.html | 0001477932-26-005892 |
| Document: 0001477932-26-005892-index.html | 0001477932-26-005892 |
| Document: 0001477932-26-005892.txt | 0001477932-26-005892 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | SC 13D | $0.6897 $0.6000 | ▼ −13.01% | ▼ −11.04% | $0.6500 (−5.76%) |
Oct 9, 2026 17d ago | 3 | $0.6897 $0.6000 | ▼ −13.01% | ▼ −11.04% | $0.6500 (−5.76%) |
Oct 9, 2026 17d ago | 8-K | $0.6897 $0.6000 | ▲ +13.01% | ▲ +11.04% | $0.6500 (+5.76%) |
Sep 29, 2026 27d ago | 8-K | $0.6897 $0.6897 | · 0.00% | ▲ +1.95% | $0.6500 (+5.76%) |
Jun 29, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
Jun 26, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
Jun 26, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers